Acute plasma amylase increase after glucagon-like peptide-1 receptor agonist exenatide administration in Type 2 diabetes

被引：3
|
作者：
Smits, M. M. [1 ]
Tonneijck, L. [1 ]
Muskiet, M. H. A. [1 ]
Diamant, M. [1 ]
Kramer, M. H. H. [1 ]
Cahen, D. L. [2 ]
van Raalte, D. H. [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Diabet Ctr, Dept Internal Med, Amsterdam, Netherlands
[2] Erasmus Univ, Dept Gastroenterol & Hepatol, Med Ctr, Rotterdam, Netherlands
来源：
DIABETIC MEDICINE | 2017年 / 34卷 / 04期
关键词：
SECRETION; LIPASE;
D O I：
10.1111/dme.13160
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：591 / 592
页数：2
相关论文
共 50 条
  • [41] Glucagon-like peptide-1 in type 2 diabetes:: the β-cell and beyond
    Nauck, Michael A.
    DIABETES OBESITY & METABOLISM, 2008, 10 : 2 - 13
  • [42] Insulin-glucagon-like peptide-1 receptor agonist relay and glucagon-like peptide-1 receptor agonist first regimens in individuals with type 2 diabetes: A randomized, open-label trial study
    Takeshita, Yumie
    Kita, Yuki
    Tanaka, Takeo
    Goto, Hisanori
    Nakano, Yujiro
    Teramura, Chisato
    Enyama, Yasufumi
    Takamura, Toshinari
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (06) : 965 - 974
  • [43] Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide
    A. Faurschou
    F. K. Knop
    J. P. Thyssen
    C. Zachariae
    L. Skov
    T. Vilsbøll
    Acta Diabetologica, 2014, 51 : 147 - 150
  • [44] Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide
    Faurschou, A.
    Knop, F. K.
    Thyssen, J. P.
    Zachariae, C.
    Skov, L.
    Vilsboll, T.
    ACTA DIABETOLOGICA, 2014, 51 (01) : 147 - 150
  • [45] Practical applications of therapy with a glucagon-like peptide-1 receptor agonist
    Shomali, Mansur E.
    JOURNAL OF FAMILY PRACTICE, 2009, 58 (09): : S35 - S43
  • [46] Glucagon-Like Peptide-1 Receptor Agonist Treatment in Liver Cirrhosis
    Hanng, Cheng
    Danpanichkul, Pojsakorn
    Muthiah, Mark
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (04)
  • [47] Glucagon-Like Peptide-1 Receptor Agonist Treatment for Pediatric Obesity
    Kelly, Aaron S.
    ADVANCED THERAPIES IN PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY, 2016, 30 : 23 - 28
  • [48] Occupational allergy to glucagon-like peptide-1 receptor agonist precurser
    Johnsen, C. R.
    Rudkjoebing, L. A.
    Bartko, E.
    ALLERGY, 2023, 78
  • [49] Exenatide, a Glucagon-like Peptide-1 Receptor Agonist, Acutely Inhibits Intestinal Lipoprotein Production in Healthy Humans
    Xiao, Changting
    Bandsma, Robert H. J.
    Dash, Satya
    Szeto, Linda
    Lewis, Gary F.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (06) : 1513 - 1519
  • [50] Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients
    ten Kulve, Jennifer S.
    van Bloemendaal, Liselotte
    Balesar, Rawien
    IJzerman, Richard G.
    Swaab, Dick F.
    Diamant, Michaela
    la Fleur, Susanne E.
    Alkemade, Anneke
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (05): : 2122 - 2129
12345